Adamis pharmaceuticals announces closing of $8.0 million public offering

San diego, aug. 04, 2023 (globe newswire) -- adamis pharmaceuticals corporation (nasdaq: admp), a commercial-stage biopharmaceutical company, today announced the closing of its public offering of 5,930,000 units, with each unit consisting of one share of common stock (or pre-funded warrant in lieu thereof) and one warrant to purchase one share of common stock. each unit was sold at a public offering price of $1.35. the common warrants are immediately exercisable at a price of $1.35 per share and expire five years from the date of issuance. the shares of common stock (or pre-funded warrants in lieu thereof) and accompanying common warrants were only purchasable together in this offering, but were issued separately and immediately separable upon issuance.
ADMP Ratings Summary
ADMP Quant Ranking